(Q51143204)

31 March 2018

title

Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota. (English)

1 reference

31 March 2018

author name string

Peijun Tian

1

1 reference

31 March 2018

Baolong Li

2

1 reference

31 March 2018

Canxia He

3

1 reference

31 March 2018

Wei Song

4

1 reference

31 March 2018

Aiju Hou

5

1 reference

31 March 2018

Sicong Tian

6

1 reference

31 March 2018

Xinyu Meng

7

1 reference

31 March 2018

Kaikai Li

8

1 reference

31 March 2018

Yujuan Shan

9

1 reference

31 March 2018

publication date

1 September 2016

1 reference

31 March 2018

published in

Food & Function

1 reference

31 March 2018

volume

7

1 reference

31 March 2018

issue

9

1 reference

31 March 2018

page(s)

3789-3797

1 reference

31 March 2018

A metagenome-wide association study of gut microbiota in type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

The gut microbiome as therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Gut microbiota, probiotics and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Targeting gut microbiota as a possible therapy for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Targeting gut microbiota in obesity: effects of prebiotics and probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Induction of HT-29 cells apoptosis by lactobacilli isolated from fermented products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Polysaccharide from seeds of Plantago asiatica L. affects lipid metabolism and colon microbiota of mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Comparative diversity analysis of gut microbiota in two different human flora-associated mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Contamination profiles of antibiotic resistance genes in the sediments at a catchment scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

The endocannabinoid system links gut microbiota to adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Use of D-lactic acid measurements in the diagnosis of bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Extrapancreatic insulin-producing cells in multiple organs in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6FO00831C

21 January 2018

Identifiers

DOI

10.1039/C6FO00831C

1 reference

31 March 2018

release_wtfhf7wesfbdnp6jn7nvemauxe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wtfhf7wesfbdnp6jn7nvemauxe

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

27713957

1 reference

31 March 2018